The two stocks have been trending in different directions for months. Here's what that says about the broader market.
Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback